Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Collaboration is based on Oncodesign’s Nanocyclix® technology and TiumBio’s fibrosis-centered R&D expertise Agreement also foresees option for in-licensing global development...








